BioSpace

In this bonus episode, BioSpace Managing Editor Jef Akst and Angela Gabriel, content manager, life sciences careers, look at the Q2 job market and discuss encouraging signs for job seekers.

In this episode of Denatured, you’ll hear from Jack Crawford, CEO of Demetra, and Magnus Gustavsson, chief commercial officer at NorthX Biologics. We unpack the evolution of cell line development — CHO cells, targeted integration, transposases and the collaboration models speeding biologics from sequence to GMP.

Host
Jennifer C. Smith-Parker, Director of Insights, BioSpace

Guests
Jack Crawford, CEO, Demeetra
Magnus Gustafsson, Chief Commercial Officer, NorthX Biologics

Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

A surprising deal from Vertex Pharmaceuticals adds to Big Pharma’s acquisitive streak as Crinetics folds into the cystic fibrosis drugmaker. Meanwhile, IPOs and venture capital raises trend upward, but mostly for derisked companies. Plus, FDA decisions slow only slightly as the hunt for a permanent leader drags on.

The vibe at BIO 2026 in San Diego last week was overwhelmingly positive, with attendees observing noticeable changes at the FDA and an uptick in dealmaking and IPOs. Plus, a top medical journal this week retracted a pivotal study for Amgen’s rare disease drug Tavneos, which has been in the FDA’s crosshairs since January.

In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you’ll hear from Hakan Goker, managing director at M Ventures and Maina Bhaman, partner at Sofinnova Partners. We explore the UK biotech ecosystem : from the Golden Triangle’s evolving role to the challenges of scaling companies, unlocking pension capital and staying globally competitive.
 
Host
 
Jennifer C. Smith-Parker, Director of Insights, BioSpace
 
Guests
 
Hakan Goker, Managing Director, M Ventures
Maina Bhaman, Partner, Sofinnova Partners
 
Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.